This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1988 Apr;9(4):127-9.

doi: 10.1016/0165-6147(88)90193-9.

Is the anticonvulsant mechanism of valproate linked to its interaction with the cerebral gamma-hydroxybutyrate system?

P Vayer, C D Cash, M Maitre

PMID: 3149808
DOI: 10.1016/0165-6147(88)90193-9

Review

Is the anticonvulsant mechanism of valproate linked to its interaction with the cerebral gamma-hydroxybutyrate system?

P Vayer et al. Trends Pharmacol Sci. 1988 Apr.

. 1988 Apr;9(4):127-9.

doi: 10.1016/0165-6147(88)90193-9.

Authors

P Vayer, C D Cash, M Maitre

PMID: 3149808
DOI: 10.1016/0165-6147(88)90193-9

No abstract available

PubMed Disclaimer

Similar articles

Effect of anticonvulsant drugs on gamma-hydroxybutyrate release from hippocampal slices: inhibition by valproate and ethosuximide.
Vayer P, Charlier B, Mandel P, Maitre M. Vayer P, et al. J Neurochem. 1987 Oct;49(4):1022-4. doi: 10.1111/j.1471-4159.1987.tb09989.x. J Neurochem. 1987. PMID: 3114427
Evidence for the participation of a cytosolic NADP+-dependent oxidoreductase in the catabolism of gamma-hydroxybutyrate in vivo.
Kaufman EE, Nelson T. Kaufman EE, et al. J Neurochem. 1987 Jun;48(6):1935-41. doi: 10.1111/j.1471-4159.1987.tb05758.x. J Neurochem. 1987. PMID: 3106576
Oxidation of gamma-hydroxybutyrate to succinic semialdehyde by a mitochondrial pyridine nucleotide-independent enzyme.
Kaufman EE, Nelson T, Miller D, Stadlan N. Kaufman EE, et al. J Neurochem. 1988 Oct;51(4):1079-84. doi: 10.1111/j.1471-4159.1988.tb03071.x. J Neurochem. 1988. PMID: 3138385
Function of gamma-hydroxybutyrate: a putative neurotransmitter.
Mandel P, Maitre M, Vayer P, Hechler V. Mandel P, et al. Biochem Soc Trans. 1987 Apr;15(2):215-7. doi: 10.1042/bst0150215. Biochem Soc Trans. 1987. PMID: 2884150 Review. No abstract available.
Gamma-hydroxybutyrate, a possible neurotransmitter.
Vayer P, Mandel P, Maitre M. Vayer P, et al. Life Sci. 1987 Sep 28;41(13):1547-57. doi: 10.1016/0024-3205(87)90721-1. Life Sci. 1987. PMID: 2887998 Review. No abstract available.

See all similar articles

Cited by

Clinical pharmacokinetics of valproic acid--1988.
Zaccara G, Messori A, Moroni F. Zaccara G, et al. Clin Pharmacokinet. 1988 Dec;15(6):367-89. doi: 10.2165/00003088-198815060-00002. Clin Pharmacokinet. 1988. PMID: 3149565 Review.
Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain.
Löscher W. Löscher W. Neurochem Res. 1993 Apr;18(4):485-502. doi: 10.1007/BF00967253. Neurochem Res. 1993. PMID: 8097295 Review.
Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.
Löscher W. Löscher W. CNS Drugs. 2002;16(10):669-94. doi: 10.2165/00023210-200216100-00003. CNS Drugs. 2002. PMID: 12269861 Review.
Suppression of preoptic GABA release caused by push-pull-perfusion with sodium valproate.
Wolf R, Tscherne U, Emrich HM. Wolf R, et al. Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):658-63. doi: 10.1007/BF00165631. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 3149723
Valproate: past, present, and future.
Johannessen CU, Johannessen SI. Johannessen CU, et al. CNS Drug Rev. 2003 Summer;9(2):199-216. doi: 10.1111/j.1527-3458.2003.tb00249.x. CNS Drug Rev. 2003. PMID: 12847559 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information